Covered recipient · General Payments record
HARVARD BRETT HEATH
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,851.87
- Reported across 166 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $360.69 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $86.72 | 5 |
| Astellas Pharma US Inc | $66.56 | 2 |
| ABBVIE INC. | $43.27 | 2 |
| PFIZER INC. | $32.82 | 2 |
| SANOFI PASTEUR INC. | $28.20 | 1 |
| Exact Sciences Corporation | $24.98 | 1 |
| Amgen Inc. | $21.92 | 1 |
| Mylan Specialty L.P. | $20.90 | 1 |
| Novo Nordisk AS | $17.66 | 1 |
| Acerta Pharma LLC | $17.66 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.08 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103897878 | CMS |
| ABBVIE INC. | $26.19 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103897880 | CMS |
| Amgen Inc. | $21.92 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117274397 | CMS |
| Astellas Pharma US Inc | $32.15 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139371905 | CMS |
| Astellas Pharma US Inc | $34.41 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139442852 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.66 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104692312 | CMS |
| Exact Sciences Corporation | $24.98 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114697273 | CMS |
| Lilly USA, LLC | $14.15 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134979850 | CMS |
| Lilly USA, LLC | $16.68 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135021512 | CMS |
| Lilly USA, LLC | $16.75 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135014543 | CMS |
| Lilly USA, LLC | $22.28 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134979852 | CMS |
| Lilly USA, LLC | $16.86 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134999152 | CMS |
| Mylan Specialty L.P. | $20.90 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147297365 | CMS |
| Novo Nordisk Inc | $17.66 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097575787 | CMS |
| PFIZER INC. | $17.32 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131756846 | CMS |
| PFIZER INC. | $15.50 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132092710 | CMS |
| SANOFI PASTEUR INC. | $28.20 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128739792 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.